|
ATF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.982300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.299900E-03 |
| Normal-vs-Stage2 |
1.918910E-03 |
| Normal-vs-Stage3 |
8.25060000000377E-05 |
| Normal-vs-Stage4 |
5.82849999999357E-05 |
| Stage1-vs-Stage2 |
5.330200E-01 |
| Stage1-vs-Stage3 |
1.637720E-03 |
| Stage1-vs-Stage4 |
1.015690E-03 |
| Stage2-vs-Stage3 |
9.662200E-02 |
| Stage2-vs-Stage4 |
5.874200E-02 |
| Stage3-vs-Stage4 |
6.286000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.574300E-04 |
| Normal-vs-AfricanAmerican |
1.580850E-03 |
| Normal-vs-Asian |
1.006690E-04 |
| Caucasian-vs-AfricanAmerican |
9.644600E-01 |
| Caucasian-vs-Asian |
9.286000E-02 |
| AfricanAmerican-vs-Asian |
1.959830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.779100E-04 |
| Normal-vs-Female |
1.844880E-03 |
| Male-vs-Female |
1.708200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.106500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.755300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.592900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.003100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.906200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.464000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.018600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.820000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.879600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.299000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.675800E-01 |
| Normal-vs-Grade 2 |
3.561000E-03 |
| Normal-vs-Grade 3 |
1.988550E-04 |
| Normal-vs-Grade 4 |
4.23139999999878E-05 |
| Grade 1-vs-Grade 2 |
4.333600E-01 |
| Grade 1-vs-Grade 3 |
2.389000E-01 |
| Grade 1-vs-Grade 4 |
1.516440E-01 |
| Grade 2-vs-Grade 3 |
1.840070E-02 |
| Grade 2-vs-Grade 4 |
4.832500E-04 |
| Grade 3-vs-Grade 4 |
1.279210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.586000E-04 |
| Normal-vs-ccB subtype |
1.799330E-03 |
| ccA subtype-vs-ccB subtype |
6.819600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.407300E-04 |
| Normal-vs-N1 |
8.39060000035197E-07 |
| N0-vs-N1 |
1.16089999835367E-08 |
|
|
